Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
Chunyan Lan(Xi'an Jiaotong University), Xin Huang(Shandong Provincial QianFoShan Hospital), Jundong Li(University of Virginia), JingXian Shen(Sun Yat-sen University), Jiaming Huang(Sun Yat-sen University), Jiayu Ling(Sun Yat-sen University), Haowen Yan(Lanzhou Jiaotong University), Min Zheng(Guangzhou University of Chinese Medicine), Fan Yang(Sun Yat-sen University), Wei Wei(Zhujiang Hospital), Yin Wang(Shanxi Provincial Children's Hospital), Zhimin Liu, Xinping Cao(Sun Yat-sen University), Mian He(Sun Yat-sen University), Ying Xiong(Sichuan University), Guorong Zou(Panyu District Central Hospital), Qing Liu(Tongji University), Yanhong Deng(Sun Yat-sen University)
Cited by 217
Related Papers
Feature Selection
|ACM Computing Surveys|2017|2.3k
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA
|Clinical Cancer Research|2018|456